Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Eck, M. Castro, D. Sinibaldi, W. White, K. Folliot, D. Gossage, Y. Wu, D. Raible, L. Roskos, R. Kolbeck, C. Ward (Gaithersburg, St. Louis, Seattle, United States Of America). Benralizumab effect on blood basophil counts in adults with uncontrolled asthma. Eur Respir J 2014; 44: Suppl. 58, 297

Member's Comments

No comment yet.

Related content which might interest you: Effect of baseline eosinophil count on response to CYT003-QbG10 in patients with persistent allergic asthma Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Experience with omalizumab in patients with moderate and severe asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Study on sputum differential counts in asthmatics controlled & uncontrolled on inhaled corticosteroids Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Clinical effectiveness of anti-IgE therapy in allergic severe asthma Source: International Congress 2014 – Asthma and COPD management Year: 2014 Elevated blood eosinophil is a risk factor for future exacerbations in asthmatic children Source: International Congress 2014 – Paediatric asthma: markers and molecules Year: 2014 Characteristics of the adult corticosteroid-dependent severe asthma in UBIOPRED consortium Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 Cytological and mRNAs peripheral blood markers of aspirin intolerance in asthmatics Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Blood eosinophil dose response to oral corticosteroids in a population of patients with severe asthma Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 A randomized phase 3 study of reslizumab efficacy in relation to blood eosinophil levels in patients with moderate to severe asthma Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases Year: 2014 Small airway indices, bronchodilator response and asthma control in children Source: International Congress 2014 – Paediatric asthma: lung function testing and more Year: 2014 Using induced sputum cell counts to guide management of difficult-to-treat asthmatics Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 LATE-BREAKING ABSTRACT: Effects of a dual CysLT1/2 antagonist, ONO-6950, on allergen-induced airway responses in subjects with mild allergic asthma. Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 LATE-BREAKING ABSTRACT: Oral corticosteroid-sparing effect of mepolizumab in severe eosinophilic asthma: the SIRIUS study Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment Year: 2014 Adherence to the treatment of patients with bronchial asthma Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Importance of concomitant local and systemic eosinophilia in uncontrolled asthma Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Improved effects of aerosol-type fluticasone propionate/formoterol combination on residual asthmatic inflammation in distal airways of patients with moderate asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients Source: International Congress 2016 – Asthma management Year: 2016 The usefulness of FeNO and the mannitol test in detecting airway eosinophilia in asthma patients with uncontrolled symptoms Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Effectively targeting small airways using controlled inhalation for peripheral corticosteroid deposition Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Clinical effectiveness of anti-IgE therapy in severe asthma with fungus sensitization Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014